Trials / Completed
CompletedNCT01485679
18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the Pancreas
Evaluation of 18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the Pancreas
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 126 (actual)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate whether the TEP-CT can be sensitive and specific in identifying degenerated intraductal papillary mucinous tumor of the pancreas.The results will be compared to those obtained by the pathological analysis of the removed piece of pancreas.
Detailed description
Before surgery is undertaken, a 18 fluoro-deoxy-glucose positrons emission tomography combined with computed tomography (18-FDG TEP-CT ) will be performed. The primary outcome of this study is to compare results of the TEP-CT with those obtained by the pathological analysis of the removed piece of pancreas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 18 fluoro-deoxy-glucose positrons emission tomography combined with computed tomography | 18 fluoro-deoxy-glucose positrons emission tomography combined with computed tomography |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2011-12-05
- Last updated
- 2016-05-18
Locations
12 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01485679. Inclusion in this directory is not an endorsement.